21 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2315

Biocytogen Pharmaceuticals (Beijing)
HK$7.45-3.5%-63.7%HK$3.0bHK$15.39PS3.9xE100.1%n/a

1477

Ocumension Therapeutics
HK$6.943.6%-20.9%HK$4.8bHK$9.38PS18.1xE93.7%n/a

1801

Innovent Biologics
HK$40.702.6%25.4%HK$66.3bHK$55.78PS9.9xE50.5%n/a

9995

RemeGen
HK$16.40-24.1%-62.2%HK$13.9bHK$39.40PS6.6xE54.9%n/a

1952

Everest Medicines
HK$20.405.2%-2.6%HK$6.5bHK$28.12PS48.3xE76.3%n/a

1548

Genscript Biotech
HK$10.008.8%-38.7%HK$21.3bHK$24.14PS3.2xE97.9%0%

9966

Alphamab Oncology
HK$2.340.4%-75.0%HK$2.3bHK$4.28PS9.6xE64.2%n/a

2616

CStone Pharmaceuticals
HK$1.18-4.1%-54.4%HK$1.5bHK$2.91PS3xE98.1%n/a

6185

CanSino Biologics
HK$19.48-3.6%-27.0%HK$7.7bHK$27.61PS12.1xE124.6%0%

2268

WuXi XDC Cayman
HK$16.182.8%n/aHK$19.4bHK$30.95PE63.5xE44.6%n/a

1681

Consun Pharmaceutical Group
HK$5.88-0.3%14.8%HK$4.9bHK$8.22PE5.7xE14.2%10.1%

1521

Frontage Holdings
HK$0.866.2%-61.6%HK$1.7bHK$1.54PE20.6xE34.9%n/a

2696

Shanghai Henlius Biotech
HK$22.65-1.5%74.5%HK$12.3bHK$20.22PE20.9xE15.8%n/a

2186

Luye Pharma Group
HK$2.87-1.4%-20.3%HK$10.8bHK$3.05PE18.8xE26.8%0%

2005

SSY Group
HK$4.33-0.2%-4.4%HK$12.9bHK$6.23PE9.7xE15.0%3.9%

2096

Simcere Pharmaceutical Group
HK$5.701.6%-24.8%HK$14.4bHK$8.53PE18.7xE23.7%3.1%

3613

Beijing Tong Ren Tang Chinese Medicine
HK$8.95-0.3%-33.2%HK$7.5bHK$13.93PE13.9xE15.2%3.7%

2269

WuXi Biologics (Cayman)
HK$11.461.8%-72.0%HK$47.6bHK$22.52PE13xE14.0%n/a

2877

China Shineway Pharmaceutical Group
HK$8.16-2.6%-1.7%HK$6.2bHK$15.09PE5.9xE13.0%7.1%

6826

Shanghai Haohai Biological Technology
HK$33.000.5%38.9%HK$13.9bn/aPE16.5xE18.2%1.7%

512

Grand Pharmaceutical Group
HK$4.811.3%10.3%HK$16.8bn/aPE9xE13.9%5.4%
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.